Frank‐Thorsten Hafner

Pharmacologic activity and pharmacokinetics of metabolites of regorafenib in preclinical models

Dieter Zopf, Iduna Fichtner, Ajay Bhargava et al. · Cancer Medicine · 2016 · 100 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma

Maria Kissel, Sandra Berndt, Lukas Fiebig et al. · Oncotarget · 2017 · 60 citations · Full text

Medicine, Oncology, Pharmacology +11

A rapid and sensitive method for determination of sorafenib in human plasma using a liquid chromatography/tandem mass spectrometry assay

Ming Zhao, Michelle A. Rudek, Ping He et al. · Journal of Chromatography B · 2006 · 53 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Mass balance, metabolic disposition, and pharmacokinetics of a single oral dose of regorafenib in healthy human subjects

Michael Gerisch, Frank‐Thorsten Hafner, Dieter Lang et al. · Cancer Chemotherapy and Pharmacology · 2017 · 45 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Determination of Regorafenib (Bay 73-4506) and its Major Human Metabolites Bay 75-7495 (M-2) and Bay 81-8752 (M-5) in Human Plasma by Stable-Isotope Dilution Liquid Chromatography–Tandem Mass Spectrometry

Frank‐Thorsten Hafner, Daniel Werner, Michael G. Kaiser · Bioanalysis · 2014 · 29 citations

Pharmacy, Pharmaceutics, Pharmacology +17